Genscript Biotech Reports 2021 Annual Results

Revenue of the Group for the year ended December 31, 2021 was approximately US$511.1 million, representing an increase of 30.8% as compared with approximately...

Related Keywords

China ,Nanjing ,Jiangsu ,Patrick Liu ,Genscript Probio ,Revenue Of The Group ,Genscript Group ,Reporting Period ,Script Biotech ,Legend Biotech ,Four Business ,Mainland China ,Follow On Public Offering ,Genscript Biotech Corporation ,Health Care Amp Hospitals ,Banking Amp Financial Services ,Biotechnology ,Earnings ,